stars 1 stars 2 stars 3

Cellectis is developing the first of its kind allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients. As a clinical-stage biopharmaceutical company with over 24 years of expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN®, its proprietary gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to target and eradicate cancer cells. As part of its commitment to a cure, Cellectis remains dedicated to its goal of providing life-saving UCART product candidates to address unmet needs for multiple cancers including B-cell acute lymphoblastic leukemia (B-ALL), non-Hodgkin lymphoma (NHL) and acute myeloid leukemia (AML). Cellectis headquarters are in Paris, France, with additional locations in New York, New York and Raleigh, North Carolina. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find out more about us, visit our website: To learn more about our community guidelines, visit: Follow our other social media accounts: @cellectis on Twitter and Cellectis YouTube TALEN® is a registered trademark owned by the Cellectis Group.

View Top Employees from Cellectis
Ticker CLLS
Revenue $41.4 million
Funding $478.9 million
Employees 261 (261 on RocketReach)
Founded 1999
Address 8 Rue De La Croix Jarry, Paris, Ile-de-France 75013, FR
Phone +33 1 81 69 16 00
Fax +33 1 81 69 16 06
Industry Biotechnology Research, Pharmaceuticals, Biopharma, Gene editing, Healthcare, Biotechnology, Life sciences, Health Care, Oncology, Science and Engineering, T-Cell therapies, Medical, Genome Engineering
Web Rank 928761
Keywords Gene Editing, Cancer Treatment, Cell Therapies
SIC SIC Code 873 Companies, SIC Code 87 Companies
NAICS NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 62 Companies, NAICS Code 325 Companies, NAICS Code 621 Companies

Cellectis Questions

The Cellectis annual revenue was $41.4 million in 2024.

261 people are employed at Cellectis.

Cellectis is based in Paris, Ile-de-France.

The NAICS codes for Cellectis are [3254, 32541, 32, 62, 325, 621].

The SIC codes for Cellectis are [873, 87].

Top Cellectis Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users